Cancer in liver transplant recipients: Management and outcomes

Asia-Pacific Journal of Clinical Oncology

Volumn 9, Issue 3, 2013, Pages 257-264

  Martin, Hilary L ^a   Chen, John Wc ^a   Koczwara, Bogda ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Liver transplantation recipient; Medical oncology; Post transplantation malignancy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; SORAFENIB;

ADULT; AGED; ANOREXIA; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CARCINOID; CHEMORADIOTHERAPY; COLORECTAL CANCER; DRUG DOSE REDUCTION; FATIGUE; FEMALE; GLIOBLASTOMA; GRAFT RECIPIENT; HEAD AND NECK CANCER; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT; LOCAL THERAPY; LUNG SMALL CELL CANCER; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL AUDIT; MELANOMA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MYCOSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STOMATITIS; WIDE EXCISION;

LIVER TRANSPLANTATION RECIPIENT; MEDICAL ONCOLOGY; POST-TRANSPLANTATION MALIGNANCY;

ADULT; CLINICAL AUDIT; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84882670701     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12041     Document Type: Article

References (21)

1. Herrero JI, Lorenzo M, Quiroga J etal. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11: 89-97.
2. Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1: 702-705.
3. O'Donovan P, Perrett CM, Zhang X etal. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874.
4. Kelly GE, Meikle W, Sheil AG. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 1987; 44: 429-434.
5. Servilla KS, Burnham DK, Daynes RA. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation 1987; 44: 291-295.
6. Euvrard S, Kanitakis J. Skin cancers after liver transplantation: what to do? J Hepatol 2006; 44: 27-32.
7. Benlloch S, Berenguer M, Prieto M etal. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4: 596-604.
8. Lynch SV, Balderson GA. ANZLT Registry Report 2010. Australian and New Zealand Liver Transplant Registry, Brisbane 2010.
9. Anderson LA, Pfeiffer R, Warren JL etal. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008; 17: 3069-3075.
10. Ulcickas Yood M, Quesenberry CP, Jr, Guo D etal. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007; 46: 107-112.
11. Lim ST, Fei G, Quek R etal. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007; 79: 132-137.
12. Herrero JI. De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl 2009; 15 (Suppl 2): S90-94.
13. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009; 137: 2010-2017.
14. Ries LAG, Melbert D, Krapcho M etal. (eds). SEER Cancer statistics review, 1975-2005, National Cancer Institute. Bethesda, MD. [Cited 23 October 2012]. Available from URL: http://seer.cancer.gov/csr/1975_2005.
15. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
16. Pettengell R, Johnson HE, Lugtenburg PJ etal. Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Support Care Cancer 2012; 20: 647-652.
17. Wildiers H, Reiser M. Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma. Crit Rev Oncol Hematol 2011; 77: 221-240.
18. Pettengell R, Schwenkglenks M, Bosly A. Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy. Ann Hematol 2008; 87: 429-430.
19. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222-230.
20. Kim JY, Ju MK, Kim MS etal. Clinical characteristics and treatment outcomes of colorectal cancer in renal transplant recipients in Korea. Yonsei Med J 2011; 52: 454-462.
21. Finkenstedt A, Graziadei IW, Oberaigner W etal. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant 2009; 9: 2355-2361.